Vera Therapeutics Inc (VERA)
41.38
-0.56
(-1.34%)
USD |
NASDAQ |
May 17, 16:00
41.38
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Total Assets (Quarterly): 419.36M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 419.36M |
| December 31, 2023 | 175.55M |
| September 30, 2023 | 175.62M |
| June 30, 2023 | 195.18M |
| March 31, 2023 | 209.60M |
| December 31, 2022 | 131.44M |
| September 30, 2022 | 131.37M |
| Date | Value |
|---|---|
| June 30, 2022 | 148.78M |
| March 31, 2022 | 164.97M |
| December 31, 2021 | 83.75M |
| September 30, 2021 | 91.17M |
| June 30, 2021 | 97.65M |
| March 31, 2021 | 51.82M |
| December 31, 2020 | 54.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
51.82M
Minimum
Mar 2021
419.36M
Maximum
Mar 2024
152.20M
Average
140.11M
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 23.92B |
| Alpine Immune Sciences Inc | 373.65M |
| Fate Therapeutics Inc | 569.89M |
| Mersana Therapeutics Inc | 198.37M |
| Equillium Inc | 43.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 65.81M |
| Shareholders Equity (Quarterly) | 353.54M |